Prevalence and severity of liver disease in patients with β thalassemia major. A single-institution fifteen-year experience

Haematologica

Volumn 90, Issue 8, 2005, Pages 1136-1138

  Perifanis, Vassilios ^a   Tziomalos, Konstantinos ^a,b   Tsatra, Ioanna ^a   Karyda, Stavroula ^a   Patsiaoura, Kallioyi ^a   Athanassiou Metaxa, Miranda ^a  

^a Aristotle University of Thessaloniki   (Greece)

^b NONE   (Greece)

Author keywords

thalassemia; Cirrhosis; HCV infection; Hemosiderosis; Liver disease

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; DISEASE SEVERITY; EXPERIENCE; FEMALE; HIGH RISK PATIENT; HUMAN; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; SCREENING; THALASSEMIA MAJOR;

BETA-THALASSEMIA; EXONS; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; LIVER DISEASES; MUTATION; PREVALENCE; RESTRICTION MAPPING; RETROSPECTIVE STUDIES;

EID: 24944522397     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, et al. Survival and causes of death in thalassaemia major. Lancet 1989;2:27-30.
2. Prati D, Maggioni M, Milani S, Cerino M, Cianciulli P, Coggi G, et al. Cooleycare Cooperative Group. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases. Haematologica 2004;89:1179-86.
3. Prati D, Zanella A, Farma E, De Mattei C, Bosoni P, Zappa M, et al. A multicentre prospective study on the risk of acquiring liver disease in anti-HCV negative patients affected from homozygous β-thalassemia. The Cooleycare Cooperative Group. Blood 1998;92:3460-4.
4. Prati D. Benefits and complications of regular blood transfusion in patients with β-thalassaemia major. Vox Sang 2000;79:129-37.
5. Prati D. Transmission of viral hepatitis by blood and blood derivatives: current risks, past heritage. Dig Liver Dis 2002;34:812-7.
6. Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Giardini C, et al. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995;89:757-61.
7. Angelucci E, Baronciani D, Lucarelli G, Giardini C, Galimberti M, Polchi P, et al. Liver iron overload and liver fibrosis in thalassemia. Bone Marrow Transplant 1993;12 Suppl 1:29-31.
8. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000;21:49-98.
9. Pietrangelo A. Iron, oxidative stress and liver fibrogenesis. J Hepatol 1998;28 Suppl 1:8-13.
10. Angelucci E, Muretto P, Nicolucci A, Baronciani D, Erer B, Gaziev J, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002;100:17-21.